Shares of Provention Bio soared Monday after the biopharmaceutical company agreed to be acquired by France’s Sanofi (SNY) for $25 a share, or about $2.9 billion. Provention Bio (ticker: PRVB), which f...
Tag: Pharmaceuticals
First Republic, Provention Bio, Roku, Illumina, Boeing, and More Market Movers
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...
Sanofi to buy Provention Bio in deal worth $2.9 billion
French pharmaceutical group Sanofi said Monday that it will buy Provention Bio, Inc., a U.S.-based biopharmaceutical company focused on autoimmune diseases, for $25 per share in cash, in a deal with a...
Novavax Says ‘Substantial Doubt’ Around Its Continuing Operations
Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this year. In a quarterly earnings report issued after the market c...
This is what Warren Buffett, a self-described ‘so-so investor,’ says is his ‘secret sauce’
Stocks are rebounding on the heels of a rotten week — the worst since December for the S&P 500 SPX, +1.15% and the Nasdaq Composite COMP, +1.39%. And as Wall Street analysts go dark, with talk of ...
Nearing retirement? Here’s how to shift your portfolio from growth to income.
Over the decades, perhaps you’ve been very good at saving your money and investing it for long-term growth. But when the time comes for you to stop working or to step back to a part-time job, you migh...
Crispr Therapeutics: FDA Filing on Sickle Cell Gene Therapy Is Almost Done
An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said, highlighting the company’s lead in a competitive area of medical research and ...
China’s Newest Weapon to Nab Western Technology—Its Courts
The growing conflict between China and the U.S. extends from computer-chip factories to a suspected spy balloon over American skies. Running through it all is a struggle for technological superiority....
Biden says three recently downed aerial objects were not linked to Chinese spy program
WASHINGTON — U.S. President Joe Biden said Thursday that three unmanned aerial objects shot down over the weekend by the U.S. military were “most likely tied to private companies, recreation or ...
Biden outlines plans to cut U.S. deficit by $2 trillion over the next decade
(The stream is slated to start at 2:30 p.m. ET. Please refresh the page if you do not see a video above at that time.) U.S. President Joe Biden is in Lanham, Maryland today where he will speak to the ...
The hunt for stocks with rising dividends: These fund managers have a strategy to keep your payouts growing
The broad stock-market rally so far in 2023 might make it easy to forget what a rough ride investors faced last year. It was a time when some active strategies focused on dividends, good cash-flow tre...
Senate holds first hearing on the suspected Chinese spy balloon
(The stream is slated to start at 10:15 a.m. ET. Please refresh the page if you do not see a video above at that time.) The Senate on Thursday is holding its first hearing on the Chinese spy balloon t...
Senate Foreign Affairs Committee holds a hearing on U.S.-China policy
The Senate Foreign Relations Committee is holding a hearing titled “Evaluating U.S.-China Policy in the Era of Extreme Competition.” The hearing comes two days after President Joe Biden hi...
U.S. House Speaker Kevin McCarthy speaks on the debt ceiling
(The stream is slated to start at 5:30 p.m. ET. Please refresh the page if you do not see a video above at that time.) House Speaker Kevin McCarthy will deliver an address Monday on the debt ceiling. ...
Gilead stock jumps 5% after Q4 beat, dividend increase
Shares of Gilead Sciences Inc. GILD, -3.11% rose more than 5% in the extended session Thursday after the pharma company reported fourth-quarter earnings and sales above Wall Street expectations, sayin...
There’s still too much risk in stock and bond markets. Earn this easy 4.5% return while you wait for stability, says trader who hit 2 big calls in 2022.
Ahead of major tech earnings later, Meta results are lighting up the Nasdaq Composite COMP, +2.97% for Thursday. The S&P 500 SPX, +1.40% is also up as investors take a glass-half full view of the ...
Pfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales.
Pfizer executives say Wall Street analysts haven’t understood just how powerful a hit the company’s Covid-19 products will take this year. That’s the explanation the company’s chief financial officer,...
These 2 dividend-stock ETFs are more like growth funds in disguise. Can either still work in your income portfolio?
Quality-stock and dividend-focused strategies shined during the market declines of 2022, rebounding from what investors may have found to be disappointing performance during the previous long bull mar...
Blackstone Stock Is a Good Investment, Even in a Downbeat Economy
These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...
Opinion: The stock market is telling you loud and clear: Now is not the time to fight the Fed or stand up to the bears.
The S&P 500 Index SPX, -1.85% hit resistance this week when an oversold rally failed near the 4080 level. This continues to support the idea that the index’s rise above 4100 in early February was ...